A gene signature for post-infectious chronic fatigue syndrome
暂无分享,去创建一个
[1] T. Chiba,et al. Blockade of CXCL12/CXCR4 Axis Ameliorates Murine Experimental Colitis , 2008, Journal of Pharmacology and Experimental Therapeutics.
[2] T. Kawai,et al. Identification of Marker Genes for Differential Diagnosis of Chronic Fatigue Syndrome , 2008, Molecular medicine.
[3] Paul Kellam,et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. , 2008, The Journal of infectious diseases.
[4] B. Burke,et al. Seven genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis: a detailed analysis of gene networks and clinical phenotypes , 2007, Journal of Clinical Pathology.
[5] M. Rossmann,et al. Interaction of Decay-Accelerating Factor with Coxsackievirus B3 , 2007, Journal of Virology.
[6] M. Maes,et al. Not in the mind of neurasthenic lazybones but in the cell nucleus: patients with chronic fatigue syndrome have increased production of nuclear factor kappa beta. , 2007, Neuro endocrinology letters.
[7] M. Maes,et al. Not in the mind but in the cell: increased production of cyclo-oxygenase-2 and inducible NO synthase in chronic fatigue syndrome. , 2007, Neuro endocrinology letters.
[8] W. Dunsmuir,et al. Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis. , 2007, The Journal of infectious diseases.
[9] Tsuyoshi Konishi,et al. Gene Expression Signature and the Prediction of Ulcerative Colitis–Associated Colorectal Cancer by DNA Microarray , 2007, Clinical Cancer Research.
[10] B. Evengård,et al. Increased number of Candida albicans in the faecal microflora of chronic fatigue syndrome patients during the acute phase of illness , 2007, Scandinavian journal of gastroenterology.
[11] D. Higgins,et al. Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data , 2006, BMC Bioinformatics.
[12] R. Craddock,et al. Identifying illness parameters in fatiguing syndromes using classical projection methods. , 2006, Pharmacogenomics.
[13] L. Carmel,et al. Gene expression profile of empirically delineated classes of unexplained chronic fatigue. , 2006, Pharmacogenomics.
[14] Weida Tong,et al. Gene expression profile exploration of a large dataset on chronic fatigue syndrome. , 2006, Pharmacogenomics.
[15] Eric Aslakson,et al. Polymorphisms in genes regulating the HPA axis associated with empirically delineated classes of unexplained chronic fatigue. , 2006, Pharmacogenomics.
[16] H. Gräns,et al. Gene expression profiling in the chronic fatigue syndrome , 2005, Journal of internal medicine.
[17] RAINER BREITLING,et al. Rank-based Methods as a Non-parametric Alternative of the T-statistic for the Analysis of Biological Microarray Data , 2005, J. Bioinform. Comput. Biol..
[18] Gwen Kennedy,et al. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. , 2005, Free radical biology & medicine.
[19] S T Holgate,et al. Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome , 2005, Journal of Clinical Pathology.
[20] S. Wessely,et al. Association of chronic fatigue syndrome with human leucocyte antigen class II alleles , 2005, Journal of Clinical Pathology.
[21] James F. Jones,et al. Exercise responsive genes measured in peripheral blood of women with Chronic Fatigue Syndrome and matched control subjects , 2005, BMC Physiology.
[22] Tatiana A. Tatusova,et al. Entrez Gene: gene-centered information at NCBI , 2004, Nucleic Acids Res..
[23] James F. Jones,et al. Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome , 2004, Journal of Molecular Medicine.
[24] K. Becker,et al. Antigen-Specific Gene Expression Profiles of Peripheral Blood Mononuclear Cells Do Not Reflect Those of T-Lymphocyte Subsets , 2004, Clinical Diagnostic Laboratory Immunology.
[25] Rainer Breitling,et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.
[26] G. Kennedy,et al. Increased neutrophil apoptosis in chronic fatigue syndrome , 2004, Journal of Clinical Pathology.
[27] Terence P. Speed,et al. A benchmark for Affymetrix GeneChip expression measures , 2004, Bioinform..
[28] Elizabeth R. Unger,et al. Utility of the Blood for Gene Expression Profiling and Biomarker Discovery in Chronic Fatigue Syndrome , 2003, Disease markers.
[29] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[30] T. Bucciarelli,et al. Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome , 2003, Neuroscience Letters.
[31] M. Xiong,et al. A 588-gene microarray analysis of the peripheral blood mononuclear cells of spondyloarthropathy patients. , 2002, Rheumatology.
[32] J. Vertommen,et al. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. , 2001, Life sciences.
[33] H. Butt,et al. Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome , 2000, Redox report : communications in free radical research.
[34] A. Rademaker,et al. A community-based study of chronic fatigue syndrome. , 1999, Archives of internal medicine.
[35] R. Moss,et al. TNF-α and Chronic Fatigue Syndrome , 1999, Journal of Clinical Immunology.
[36] C. Watson,et al. DNA chip technolgy , 1999, The Journal of pathology.
[37] D. T. Williams,et al. A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells , 1997, Journal of virology.
[38] S. Wessely,et al. The prevalence and morbidity of chronic fatigue and chronic fatigue syndrome: a prospective primary care study. , 1997, American journal of public health.
[39] L. Tsenova,et al. Early Lyme disease: Humoral immune status and treatment. , 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[40] J. Gow,et al. Long RT-PCR amplification of full-length enterovirus genome. , 1996, BioTechniques.
[41] S. Wessely,et al. Postinfectious fatigue: prospective cohort study in primary care , 1995, The Lancet.
[42] B. Nowicki,et al. dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor , 1995, Infection and immunity.
[43] Ian Hickie,et al. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.
[44] Dedra Buchwald,et al. Gender differences in patients with chronic fatigue syndrome , 1994, Journal of General Internal Medicine.
[45] R. Finberg,et al. Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells. , 1992, Journal of immunology.
[46] P. Behan,et al. Changes in natural killer cell phenotype in patients with post‐viral fatigue syndrome , 1991, Clinical and experimental immunology.
[47] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[48] R. Moss,et al. TNF-alpha and chronic fatigue syndrome. , 1999, Journal of clinical immunology.
[49] H. Blum,et al. [DNA chip technology]. , 1999, Deutsche medizinische Wochenschrift.
[50] P. Behan,et al. Genomic and template RNA transcription in a model of persistent enteroviral infection. , 1997, Journal of neurovirology.
[51] I. Hickie,et al. Bmc Infectious Diseases Preliminary Evidence of Mitochondrial Dysfunction Associated with Post-infective Fatigue after Acute Infection with Epstein Barr Virus , 2022 .